Related Experiment Video

Updated: Jul 9, 2026

Screening Ion Channels in Cancer Cells
06:19

Screening Ion Channels in Cancer Cells

Published on: June 16, 2023

SP600125 inhibits Kv channels through a JNK-independent pathway in cancer cells

Sonia Martial1, Jean-Luc Giorgelli, Adrien Renaudo

  • 1Université de Nice Sophia Antipolis, Faculté des Sciences, Laboratoire de Biologie et de Physiopathologie des Systèmes Intégrés, CNRS FRE3094, UNSA, 28, Av Valrose, 06108, Nice, France.

Biochemical and Biophysical Research Communications
|December 18, 2007
PubMed

Insights

The JNK inhibitor SP600125 directly blocks Kv channels, independent of JNK signaling. This finding suggests caution when using SP600125 to study JNK

Area of Science:

  • Molecular biology
  • Cancer research
  • Pharmacology

Background:

  • Potassium voltage-gated (Kv) channels are crucial in cancer progression.
  • Understanding Kv channel regulation is key for developing cancer therapeutics.
  • Mitogen-activated protein (MAP) kinases are implicated in cancer cell regulation.

Purpose of the Study:

  • To investigate the modulation of Kv channels by MAP kinases.
  • To examine the role of JNK signaling in Kv channel regulation within cancer cells.
  • To evaluate the specificity of the JNK inhibitor SP600125.

Main Methods:

  • Pharmacological inhibition of JNK signaling pathway.
  • Electrophysiological recordings of Kv channel activity.
  • Assessment of SP600125 interaction with Kv channels.

Main Results:

  • SP600125 significantly inhibits Kv channel activity.
  • This inhibition occurs through a JNK-independent mechanism.
  • SP600125 appears to directly bind to the extracellular domain of Kv channels.

Conclusions:

  • The JNK inhibitor SP600125 exhibits off-target effects on Kv channels.
  • Its use may lead to inaccurate conclusions regarding JNK's role in cell cycle regulation.
  • Further research is needed to elucidate specific Kv channel-MAP kinase interactions in cancer.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...